Ind-Swift Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)
Ind-Swift Laboratories Ltd · Outcome · 29 Oct 2026, 8:29 pm
Ind-Swift Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 24,046 (+51.6% YoY | +25.6% QoQ) ■ EBITDA: 4,546 (+508.5% YoY | +36.0% QoQ) ■ EBITDA Margin (%): 18.9 (+1420 bps YoY | +144 bps QoQ) ■ PAT: 3,422 (+328.3% YoY | +38.6% QoQ) ■ EPS (INR): 3.92 (+308.3% YoY | +38.0% QoQ)
Original exchange filing (PDF)
More announcements from Ind-Swift Laboratories Ltd
- Please find enclosed transcript for earnings call held on November 04, 2026. · 10 Nov 2026
- Audio recording of earning conference call held on 04.11.2026 on un-audited financial results for the quarter ended 30.09.2026. · 05 Nov 2026
- Please find enclosed investor presentation on un-audited financial results for the quarter ended September 30, 2026 · 04 Nov 2026
- Monitoring Agency Report for the quarter ended September 30, 2026 in respect of receipt of funds raised through preferential issue of 70,00,000 Fully Convertible Warrants · 03 Nov 2026
- Monitoring Agency Report for the quarter ended September 30, 2026 in respect of funds raised through Preferential Issue 2.6 Cr Fully Convertible Warrants · 03 Nov 2026
- Please find enclosed Schedule of Analyst / Investor Meet which will be held on Wednesday, November 04, 2026, at 04.00 P.M. IST in respect of financial results of the Company for the quarter .... · 04 Nov 2026
- Press Release in respect of Unaudited Financial Results (Standalone & Consolidated) for the second quarter and half year ended September 30, 2026 · 30 Oct 2026
- Please refer attached pdf · 30 Oct 2026
